These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 18930728

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Matsumoto T, Kobayashi T, Kamata K.
    Eur J Pharmacol; 2006 May 24; 538(1-3):132-40. PubMed ID: 16678154
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pravastatin normalizes endothelium-derived contracting factor-mediated response via suppression of Rho-kinase signalling in mesenteric artery from aged type 2 diabetic rat.
    Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T.
    Acta Physiol (Oxf); 2012 Jun 24; 205(2):255-65. PubMed ID: 22212448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abnormalities of endothelium-dependent responses in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats are improved by chronic treatment with thromboxane A2 synthase inhibitor.
    Matsumoto T, Takaoka E, Ishida K, Nakayama N, Noguchi E, Kobayashi T, Kamata K.
    Atherosclerosis; 2009 Jul 24; 205(1):87-95. PubMed ID: 19111834
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats.
    Matsumoto T, Ishida K, Nakayama N, Taguchi K, Kobayashi T, Kamata K.
    Pharmacol Res; 2010 Sep 24; 62(3):271-81. PubMed ID: 20304070
    [Abstract] [Full Text] [Related]

  • 8. Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats.
    Shi Y, Ku DD, Man RY, Vanhoutte PM.
    J Pharmacol Exp Ther; 2006 Jul 24; 318(1):276-81. PubMed ID: 16565165
    [Abstract] [Full Text] [Related]

  • 9. Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes.
    Matsumoto T, Kakami M, Noguchi E, Kobayashi T, Kamata K.
    Am J Physiol Heart Circ Physiol; 2007 Sep 24; 293(3):H1480-90. PubMed ID: 17513496
    [Abstract] [Full Text] [Related]

  • 10. Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats.
    Matsumoto T, Kobayashi T, Wakabayashi K, Kamata K.
    Am J Physiol Heart Circ Physiol; 2005 Nov 24; 289(5):H1933-40. PubMed ID: 15908466
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice.
    Pannirselvam M, Ding H, Anderson TJ, Triggle CR.
    Eur J Pharmacol; 2006 Dec 03; 551(1-3):98-107. PubMed ID: 17027963
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
    Aoki M, Morishita R, Hayashi S, Jo N, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T.
    Diabetologia; 2001 Aug 03; 44(8):1034-42. PubMed ID: 11484082
    [Abstract] [Full Text] [Related]

  • 13. Impaired endothelium-derived hyperpolarization-type relaxation in superior mesenteric arteries isolated from female Otsuka Long-Evans Tokushima Fatty rats.
    Matsumoto T, Kobayashi S, Ando M, Watanabe S, Iguchi M, Taguchi K, Kobayashi T.
    Eur J Pharmacol; 2017 Jul 15; 807():151-158. PubMed ID: 28433656
    [Abstract] [Full Text] [Related]

  • 14. Phosphodiesterase-3 inhibitor cilostazol reverses endothelial dysfunction with ageing in rat mesenteric resistance arteries.
    Moreira HS, Lima-Leal GA, Santos-Rocha J, Gomes-Pereira L, Duarte GP, Xavier FE.
    Eur J Pharmacol; 2018 Mar 05; 822():59-68. PubMed ID: 29355555
    [Abstract] [Full Text] [Related]

  • 15. Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Matsumoto T, Kobayashi T, Wachi H, Seyama Y, Kamata K.
    Atherosclerosis; 2007 May 05; 192(1):15-24. PubMed ID: 16831440
    [Abstract] [Full Text] [Related]

  • 16. Cilostazol, a phosphodiesterase inhibitor, improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty Rat, a model of spontaneous NIDDM.
    Nakaya Y, Minami A, Sakamoto S, Niwa Y, Ohnaka M, Harada N, Nakamura T.
    Diabetes Obes Metab; 1999 Jan 05; 1(1):37-41. PubMed ID: 11221811
    [Abstract] [Full Text] [Related]

  • 17. beta1 antagonist and beta2 agonist, celiprolol, restores the impaired endothelial dependent and independent responses and decreased TNFalpha in rat with type II diabetes.
    Hayashi T, Juliet PA, Miyazaki-Akita A, Funami J, Matsui-Hirai H, Fukatsu A, Iguchi A.
    Life Sci; 2007 Jan 16; 80(6):592-9. PubMed ID: 17141277
    [Abstract] [Full Text] [Related]

  • 18. Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of non-insulin-dependent diabetes mellitus.
    Kagota S, Yamaguchi Y, Nakamura K, Kunitomo M.
    Gen Pharmacol; 2000 Mar 16; 34(3):201-9. PubMed ID: 11120382
    [Abstract] [Full Text] [Related]

  • 19. Effects of angiotensin II receptor antagonist on impaired endothelium-dependent and endothelium-independent relaxations in type II diabetic rats.
    Oniki H, Fujii K, Kansui Y, Goto K, Iida M.
    J Hypertens; 2006 Feb 16; 24(2):331-8. PubMed ID: 16508581
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.